Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Will Telehealth Flexibilities Survive the September Deadline?
Digital Health Will Telehealth Flexibilities Survive the September Deadline?

As the critical deadline of September 30 approaches, the fate of Medicare telehealth flexibilities and Hospital-at-Home waivers hangs in the balance, casting uncertainty over millions of Americans who rely on virtual care for essential medical services. These provisions, which have transformed

Why Is Medicare Advantage Enrollment Declining by 2026?
Regulatory & Compliance Why Is Medicare Advantage Enrollment Declining by 2026?

Understanding the Medicare Advantage Landscape Medicare Advantage (MA), a privatized alternative to traditional Medicare, has become a cornerstone of the healthcare system for millions of seniors in the United States. Administered by private insurers under contract with the Centers for Medicare &

AI Blood Test Reveals Aging Secrets and Fitness Insights
Digital Health AI Blood Test Reveals Aging Secrets and Fitness Insights

Imagine a world where a single drop of blood could unlock the mysteries of how well someone is aging, offering a personalized roadmap to better health, and this isn’t a distant dream but a reality taking shape through groundbreaking research that harnesses artificial intelligence (AI) to analyze

Can RT-PCR Testing Cut Costs for Respiratory Infections?
Imaging & Diagnostics Can RT-PCR Testing Cut Costs for Respiratory Infections?

In the vast landscape of U.S. health care, respiratory infections stand as a towering challenge, draining resources and impacting millions of lives each year with their relentless prevalence. These conditions, encompassing acute oropharyngeal infections and broader respiratory tract infections

Realme Watch 5 Debuts with Apple Ultra Design on a Budget
Digital Health Realme Watch 5 Debuts with Apple Ultra Design on a Budget

In an era where smartwatches have become indispensable companions for fitness enthusiasts and tech-savvy individuals alike, the market is often split between premium offerings with hefty price tags and budget options that compromise on style or features. Enter the newly unveiled Realme Watch 5, a

HeartFlow Gains FDA Clearance for Advanced Plaque Analysis
Regulatory & Compliance HeartFlow Gains FDA Clearance for Advanced Plaque Analysis

In an era where heart disease remains a leading cause of mortality, claiming millions of lives annually across the globe, the demand for precise and innovative diagnostic tools has never been more critical. Imagine a technology capable of not only detecting plaque buildup in coronary arteries with

How Can AI Benefit Healthcare Workers Without Replacing Them?
Digital Health How Can AI Benefit Healthcare Workers Without Replacing Them?

Imagine a healthcare system where providers are freed from the crushing weight of administrative tasks, where technology anticipates needs before they become crises, and where patient care remains deeply human despite digital advancements. This vision is no longer a distant dream but a tangible

CDC Advisers Delay Vote on Newborn Hepatitis B Vaccine Timing
Regulatory & Compliance CDC Advisers Delay Vote on Newborn Hepatitis B Vaccine Timing

Imagine a scenario where a seemingly routine public health decision about newborn vaccinations sparks a heated debate, revealing deep divides among experts and stakeholders over how best to protect infants. Hepatitis B, a virus that can cause severe liver damage, has long been prevented through a

Are Nonprofit Hospitals Justifying Their Tax-Exempt Status?
Regulatory & Compliance Are Nonprofit Hospitals Justifying Their Tax-Exempt Status?

I'm thrilled to sit down with James Maitland, a renowned expert in healthcare policy with a deep understanding of nonprofit hospital systems and their role in American healthcare. With years of experience analyzing the intersection of policy, economics, and patient care, James offers a unique

Diagnostic Imaging Market to Reach $32.9B by 2030 with 4.4% CAGR
Imaging & Diagnostics Diagnostic Imaging Market to Reach $32.9B by 2030 with 4.4% CAGR

In an era where healthcare is increasingly reliant on precision and early detection, the global diagnostic imaging market stands as a cornerstone of modern medicine, with projections estimating its value to soar to $32.9 billion by 2030. This remarkable growth, fueled by a compound annual growth

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later